IRIS
AGUENNOUZ, M'hammed
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.811
NA - Nord America 11.204
AS - Asia 6.918
SA - Sud America 2.506
AF - Africa 256
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 11
AN - Antartide 1
Totale 34.718
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.983
RU - Federazione Russa 6.736
SG - Singapore 3.042
BR - Brasile 2.171
CN - Cina 1.977
IE - Irlanda 1.583
SE - Svezia 1.357
IT - Italia 1.215
DE - Germania 744
HK - Hong Kong 701
UA - Ucraina 512
FR - Francia 479
FI - Finlandia 415
VN - Vietnam 391
GB - Regno Unito 274
IN - India 183
PL - Polonia 173
AR - Argentina 117
CA - Canada 103
BD - Bangladesh 89
BE - Belgio 76
IQ - Iraq 70
TR - Turchia 68
ZA - Sudafrica 67
EC - Ecuador 65
MX - Messico 64
AT - Austria 58
ID - Indonesia 52
PK - Pakistan 46
MA - Marocco 45
UZ - Uzbekistan 45
JP - Giappone 44
CO - Colombia 43
CI - Costa d'Avorio 42
NL - Olanda 40
VE - Venezuela 34
CZ - Repubblica Ceca 32
CL - Cile 30
ES - Italia 25
TN - Tunisia 23
KE - Kenya 22
AZ - Azerbaigian 21
PY - Paraguay 21
SA - Arabia Saudita 20
EG - Egitto 18
KZ - Kazakistan 17
NP - Nepal 17
MY - Malesia 16
DZ - Algeria 14
LT - Lituania 14
IR - Iran 13
IL - Israele 12
LB - Libano 12
PE - Perù 11
PH - Filippine 11
AE - Emirati Arabi Uniti 10
AL - Albania 10
JM - Giamaica 10
CR - Costa Rica 9
DO - Repubblica Dominicana 9
UY - Uruguay 9
EU - Europa 8
PT - Portogallo 8
AU - Australia 7
HN - Honduras 7
KG - Kirghizistan 7
OM - Oman 7
RO - Romania 7
TH - Thailandia 7
BG - Bulgaria 6
JO - Giordania 6
PS - Palestinian Territory 6
RS - Serbia 6
SN - Senegal 6
BO - Bolivia 5
CH - Svizzera 5
GR - Grecia 5
NI - Nicaragua 5
SK - Slovacchia (Repubblica Slovacca) 5
TW - Taiwan 5
GT - Guatemala 4
KH - Cambogia 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
PA - Panama 4
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
GA - Gabon 3
HR - Croazia 3
KR - Corea 3
LV - Lettonia 3
NG - Nigeria 3
QA - Qatar 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
CY - Cipro 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
HU - Ungheria 2
Totale 34.686
Salva come PNG Salva come JPEG
Città #
Moscow 2.071
Dublin 1.582
Ashburn 1.518
Singapore 1.516
Dallas 1.373
Chandler 1.092
Jacksonville 1.063
Nyköping 830
Beijing 716
Hong Kong 701
San Jose 601
The Dalles 382
Messina 360
Princeton 295
Los Angeles 285
Medford 272
Munich 251
Lauterbourg 246
Cambridge 242
Ann Arbor 241
Des Moines 212
Dearborn 172
São Paulo 164
Warsaw 157
New York 134
Buffalo 131
Boardman 127
Ho Chi Minh City 127
Council Bluffs 101
Helsinki 91
Tianjin 88
Jinan 82
Wilmington 78
Shenyang 75
Hanoi 70
Rio de Janeiro 68
Brussels 67
San Mateo 66
Turku 66
Rome 65
Woodbridge 63
Frankfurt am Main 61
Redondo Beach 61
Guangzhou 60
Lancaster 60
Belo Horizonte 59
Orem 58
Santa Clara 55
Brooklyn 50
Hyderabad 49
Nanjing 49
Bremen 44
Abidjan 41
Houston 40
Tashkent 40
Tokyo 40
Vienna 40
Curitiba 39
Pune 38
Seattle 37
Hebei 36
Shanghai 36
Nuremberg 35
Porto Alegre 32
Brasília 31
London 31
Ningbo 30
Johannesburg 29
Catania 28
Chennai 28
Montreal 28
Zhengzhou 28
Atlanta 27
Hangzhou 27
Milan 27
Salvador 27
Taizhou 27
Caltagirone 26
Haikou 26
Campinas 24
Dong Ket 24
Guarulhos 24
Guayaquil 24
Norwalk 24
Quito 23
Toronto 23
Baghdad 22
San Francisco 22
Baku 21
Denver 21
Falls Church 21
Mumbai 21
Nairobi 21
Amsterdam 20
Brno 20
Düsseldorf 20
Phoenix 20
Changsha 19
Chicago 19
Ottawa 19
Totale 19.773
Salva come PNG Salva come JPEG
Nome #
Idrocefalo normoteso idiopatico (iNPH): nostra esperienza preliminare. 463
A NOVEL SERUM MICRORNA SIGNATURE TO SCREEN TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY 366
Clinical and pathological features of focal myositis 248
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 248
4-Methyl umbelliferone effects on cell proliferation in human glioma cells. 243
SIRT1 and SIRT2 Expression correlates with advanced disease and bone lesions in Multiple Myeloma 241
PDXK mutations cause polyneuropathy responsive to pyridoxal 5'-phosphate supplementation. 239
MiRNA expression profiling regulates necroptotic cell death in hepatocellular carcinoma 236
Mutations in the Neuronal Vesicular SNARE VAMP2 Affect Synaptic Membrane Fusion and Impair Human Neurodevelopment 233
A Nouvel serum MicroRNA signature to screen ATTR 228
Circulating miRNAs expression as potential biomarkers of mild traumatic brain injury 219
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol 218
Analisi dello stato di metilazione del promoter di O6-methylguanine DNA methyltransferase (MGMT) e TMS1/ASC nei gliomi cerebrali diffusi di basso grado: possibili implicazioni cliniche e prognostiche. 218
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 216
A cytochemical study of apoptosis in metabolic myopathies 210
A life threatening case of β-enolase deficiency 203
MDR-1 gene polymorphisms G2677T and C3435T in a case of Hodgkin's variant of Richter's syndrome 199
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 198
microRNA-10 and -221 modulate differential expression of Hippo signaling pathway in human astroglial tumors 198
Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice 194
miRNA regulation of Sirtuin-1 expression in human astrocytoma 193
A homozygous MED11 C-terminal variant causes a lethal neurodegenerative disease 192
Effect of exercise on telomere length and telomere proteins expression in mdx mice 188
Hippo signaling pathway is altered in Duchenne muscular dystrophy 186
Characterization and functional analysis of the human microRNA 363 in glioblastoma transfected cell lines 184
Analisi dello stato di metilazione del promoter di O6-methylguanine DNA methyltransferase (MGMT) e TMS1/ASC: possibili implicazioni cliniche e prognostiche nei gliomi cerebrali diffusi di basso grado 183
Autoimmunity to heterogeneous nuclear ribonucleoprotein A1 in psoriatic patients and correlation with disease severity 183
NLRP3 inflammasome CSF expression and neuropsychological changes in idiopathic normal pressure hydrocephalus 182
(+)-Lipoic Acid Reduces Lipotoxicity and Regulates Mitochondrial Homeostasis and Energy Balance in an In Vitro Model of Liver Steatosis 181
A case of vacuolar myopathy during the course of chronic hepatitis C. 180
Prognostic value of HMGB1 and oxidative stress markers in multiple trauma patients: A single-centre prospective study 180
Analysis of HBV integration in mitochondrial DNA of HepAD38 cells by the high-throughput HBV integration sequencing and RNASeq approaches 179
Expression of the tumor necrosis factor receptor-associated factors I and 2 and regulation of the nuclear factor-kappa B antiapoptotic activity in human gliomas 179
ANT1 is reduced in sporadic inclusion body myositis. 177
A novel variant of GALC in a familial case of Krabbe disease: Insights from structural bioinformatics and molecular dynamics simulation 175
ANT1 expression and RAGE-NF-kB pathway activation in sporadic inclusion-body myositis 175
Role of inflammation and oxidative stress mediators in gliomas. 175
Analysis of lipid profile in lipid storage myopathy 174
MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation 173
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis. 169
Pilot study of flavocoxid in ambulant DMD patients. 169
Type I Hyperprolinemia Associated with Epilepsy and Mental Retardation Results from PRODH Gene Mutations in Three Sicilian Children. 168
NfL as a biomarker in ATTRv amyloidosis: potential and limitations 167
Espressione differenziale di un panel di miRNA in tumori cerebrali astrogliali con diverso grado di malignità. 167
Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene 166
Activation of nuclear factor-kappa B in inflammatory myopathies and Duchenne muscular dystrophy 166
MicroRNA signatures predict dysregulated Vitamin D receptor and calcium pathways status in Limb Girdle muscle dystrophies (LGMD) 2A/2B. 165
Modulation of neural nitric oxide synthase by the isoflavone genistein promotes muscle regeneration in mdx mice 164
Methylome Analysis in Nonfunctioning and GH-Secreting Pituitary Adenomas 162
Type I hyperprolinemia and proline dehydrogenase (PRODH) mutations in four Italian children with epilepsy and mental retardation. 161
Ant1 expression and RAGE-NF-kB pathway activation in sporadic inclusion body myositis 160
Activation of nuclear factor-κB in inflammatory myopathies and Duchenne muscular dystrophy 154
Clinical and genetic characterization in two families with muscle phosphofructokinase deficiency 154
Recurrent rhabdomyolysis due to muscle β-enolase deficiency: very rare or underestimated? 154
Meccanismi anti-apoptotici nei gliomi. Ruolo dell'attività nucleare del nuclear factor-kb e dei suoi fattori di controllo. 153
A rare PANK2 deletion in the first north African patient affected with pantothenate kinase associated neurodegeneration 152
Fatal R631C mutation is also present in the adult form of CPTII deficiency 151
Expression of telomeric repeat binding factor-1 in astroglial bran tumors 150
Pilot study of flavocoxid in ambulant DMD patients. 150
MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior 150
Pilot study of flavocoxid in ambulant DMD patients. 150
Clinical, biochemical and genetic features in muscle phosphofructokinase deficiency 149
Clinical and genetic charactherization in two families with muscle phosphofructokinase deficiency 149
Activation of NF-kappaB pathway in Duchenne muscular dystrophy: relation to age 149
Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies 148
Meccanismi antiapoptotici nf-kb-mediati in gliomi umani in vivo. 148
Charcot-Marie-Tooth disease: experience from a large Italian tertiary neuromuscular center 148
MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis. 147
Severe rhabdomyolysis in a patient with “Heat Stroke” 147
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis 147
Miopatie metaboliche 146
Mutations in NKX6-2 Cause Progressive Spastic Ataxia and Hypomyelination 146
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders 146
Activation and localization of transcription factor NF-KB in peripheral neuropathies of different origin. 145
Telomere shortening is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy 145
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial 144
Sarcoglycans in cerebral cortex of the rat: an immunohistochemical and molecular study. 143
Clinical features and new molecular findings in muscle phosphofructokinase deficiency (GSD type VII). 142
Matrix Metalloproteinase 9 and Transglutaminase 2 Expression at the Ocular Surface in Patients with Different Forms of Dry Eye Disease 142
Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination 142
Telomere shortening and telomere-associated proteins in Duchenne muscular dystrophy. 141
Bi-allelic genetic variants in the translational GTPases GTPBP1 and GTPBP2 cause a distinct identical neurodevelopmental syndrome 140
miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors 140
Calpain 3 deficiency in Quail Eater's disease 139
Inverse correlation between TRF-1 (telomeric-repeat binding factor 1) and histological grade of malignant brain tumors 138
Clinical heterogeneity and molecular basis of myoadenilate deaminase deficiency 136
Evidence of calpain and caspase-3-like activation in CSF of severe human traumatic brain injury 135
Meccanismi antiapoptotici NF-kB-mediati in gliomi umani in vivo. 135
Espressione di ANT1 e attivazione della via RAGE-NF-kB nella miosite a corpi inclusi. 134
Espressione del telomeric Repeat Binding Factor-1 (TRF-1) nei tumori cerebrali della serie astrogliale: possibili implicazioni clinico-terapeutiche. 134
CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment 133
Expression of the trascription factor NFkB in different muscular dystrophies 131
Differential expression of Hippo signaling pathway in human astroglial tumors 130
study of flavocoxid in ambulant DMD patients. 129
Implication of SIRT1 and its downstream pathways in dystrophic process. 129
Meningiomas and proteomics: Focus on new potential biomarkers and molecular pathways 129
Dyscondrosteosis in a child with Becker muscular dystrophy: an unreported association between Xp21 gene (DMD/BMD) deletion and a novel homozygous SHOX gene mutation 127
Studio dell'espressione genica della metalloproteinasi 3 e degli inibitori TIMP-1 e TIMP-2 nei meningiomi cerebrali 126
Clinical eterogeneity and molecular basis of myoadenilate deaminase deficiency. 126
Novel SHOX Gene Mutation in a Short Boy with Becker Muscular Dystrophy: Double Trouble in Two Adjacent Genes. 125
Totale 17.189
Salva come PNG Salva come JPEG
Categoria #
all - tutte 115.695
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.695
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202177 0 0 0 0 0 0 0 0 0 0 0 77
2021/20221.844 14 232 31 72 96 27 138 82 35 234 238 645
2022/20234.485 371 381 232 321 348 423 72 258 1.903 17 107 52
2023/20241.196 90 186 77 92 119 220 37 79 12 92 27 165
2024/20255.928 108 61 114 333 279 184 148 1.317 1.403 354 607 1.020
2025/202616.440 871 1.234 1.419 1.160 1.198 3.537 2.087 1.867 1.962 666 294 145
Totale 35.193